KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 51 filers reported holding KARUNA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $408 | -100.0% | 2,075 | -52.0% | 0.05% | -60.5% |
| Q3 2022 | $972,000 | +57.8% | 4,322 | -11.2% | 0.13% | +40.2% |
| Q2 2022 | $616,000 | +55.2% | 4,866 | +47.5% | 0.09% | +39.4% |
| Q1 2021 | $397,000 | +18.9% | 3,299 | +0.4% | 0.07% | +20.0% |
| Q4 2020 | $334,000 | -46.2% | 3,285 | -89.4% | 0.06% | -21.4% |
| Q2 2019 | $621,000 | – | 31,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |